Jarred Mait, MD founded Pulse & Remedy with a mission to provide South Florida with premium concierge medical care that prioritizes patient needs
Why Providers Add MIC+B12 to Every Weight Loss Protocol Supports fat metabolism alongside diet and exercise Helps maintain energy levels during caloric deficit Complements GLP-1 therapy (semaglutide, tirzepatide) Supports liver function during weight loss Simple IM administration with minimal chair time Enhances fat breakdown and helps reduce stubborn fat deposits What Providers Say Real feedback from medical practices using My Kaduceus B12 Lipo
Semaglutide, which was originally created to treat type 2 diabetes, belongs to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
The global L-Carnitine market was valued at approximately USD 220.79 million in 2024 and is projected to grow significantly through 2034
et al., The increasing rate of diabetes in Pakistan: A silent killer (2022) IDF, Prevalence of Diabetes in Pakistan (2024) Jastreboff et al., NEJM, Phase 2 obesity trial of retatrutide (2023) Reuters Next generation Lilly weight-loss drug shows added heart, liver benefits (2024) Investopedia / news20 Eli Lilly shares rise after drug helps patients lose more weight than competitors (2023) Lancet Phase 2 trial on T2DM (via ResearchGate summary) PMC meta-analysis: weight/metabolic outcomes of retatrutide Anti-obesity medication (retatrutide entry) News21 (Axios) Extraordinary promise of retatrutide (2023) USA Today (American Diabetes Association summary) News25 (NY Post) re: Phase 3 status and side effects
